Select Bibliography

Filter by any of these (after searching):

Fishkin, Paul A. S.

AUTHOR ABSTRACT DEADLINES

A meeting abstract must be submitted by the first or corresponding author to the Alliance Publications Coordinator (publications@AllianceNCTN.org) at least two weeks prior to the meeting abstract submission deadline. For detailed information about Alliance Publications guidelines, please refer to the policies, along with the author abstract deadlines.

There are 1 items

Phase II Interventional Study (N0337) of Capecitabine in Combination With Vinorelbine and Trastuzumab for First- or Second-Line Treatment of HER2-Positive Metastatic Breast Cancer: A North Central Cancer Treatment Group Trial

Tan, Winston W. , Allred, Jacob B. , Salim, Muhammad , Flynn, Patrick ... - - Clin Breast Cancer - 2012

Manuscript - Primary - Primary - Breast - NCCTG-N0337